Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Sebum samples remain stable under various storage conditions, making them suitable for remote and at-home testing.

An 11-year-old Greek girl was diagnosed with a rare genetic disorder, highlighting the importance of genetic testing and family history.

The photographic method for measuring facial hair density is reliable and valid but needs further testing on different hair densities and skin colors.

Scientists created a 3D skin model to study a chronic skin disease and test treatments.

Human hair follicle organ culture is a useful model for hair research with potential for studying hair biology and testing treatments.

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

A low-cost, 3D-printed light therapy device is safe and effective but needs more testing before use on people.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Canine hypothyroidism can be linked to diabetes, requiring thorough testing for proper diagnosis.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

Early phosphorus-calcium disorders in children with chronic kidney disease can lead to bone issues, highlighting the need for early bone density testing.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Organoid technology helps create mini-organs for studying diseases and testing drugs.

Genetic testing is crucial before giving azathioprine to avoid severe side effects.

Exosomes from mesenchymal stem cells show promise for tissue repair but face challenges in isolation and safety testing.

Ludwig pattern hair loss in women results from varying sensitivity in hair follicles, causing fewer visible hairs.

Accurate diagnosis of rare hyperandrogenism conditions requires detailed testing and sometimes invasive procedures.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

This model can replace animal testing for quick, cost-effective skin toxicity tests.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

3D cell cultures are better for testing hair growth treatments than 2D cultures.

The method is effective and suitable for testing finasteride tablets.

Portable point-of-care testing can improve quick and accurate genetic disorder detection.

The study found potential new DNA patterns in fertility genes, but further testing is needed.

Organoids help study and treat genetic diseases, offering personalized medicine and therapy testing.

The document concludes that while finding animal models for the skin disease Hidradenitis suppurativa is challenging, certain mouse mutations may provide useful insights for research and drug testing.

Bioengineered skin models help reduce animal testing and advance research in cosmetics and skin disease.